Bellicum Pharmaceuticals Accounts Payable

Bellicum Pharmaceuticals (BLCM) currently reports a accounts payable of $530K as of September 2023. That compares with $710K in the prior-year period — down 26.3% year over year. Use the charts on this page to explore Bellicum Pharmaceuticals's accounts payable history and peer comparisons.

Bellicum Pharmaceuticals's accounts payable decreased from $710K to $530K — a 26.3% year-over-year decrease (period ending September 2023). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Bellicum Pharmaceuticals reported $530K in accounts payable as of September 2023. That compares with $710K in the prior-year period — down 26.3% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current accounts payable of $530K, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Bellicum Pharmaceuticals, and consider following BLCM for alerts when major investors trade the stock.

Bellicum Pharmaceuticals is classified in the Healthcare sector. On accounts payable, it currently shows $530K. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing BLCM with unrelated industries.